R. Camisa

618 total citations
18 papers, 398 citations indexed

About

R. Camisa is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, R. Camisa has authored 18 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in R. Camisa's work include Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and BRCA gene mutations in cancer (2 papers). R. Camisa is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and BRCA gene mutations in cancer (2 papers). R. Camisa collaborates with scholars based in Italy, United States and Portugal. R. Camisa's co-authors include Andrea Ardizzoni, Francesca Negri, Pellegrino Crafa, Cecilia Bozzetti, Costanza Annamaria Lagrasta, Rita Nizzoli, Francesca Pucci, Maria Paola Bonasoni, Giulia Gardini and Giuseppe Pedrazzi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

R. Camisa

17 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Camisa Italy 9 300 219 105 68 65 18 398
Anghel Adrian Udrea United States 8 261 0.9× 227 1.0× 96 0.9× 44 0.6× 96 1.5× 15 392
C. Funaioli Italy 7 235 0.8× 254 1.2× 90 0.9× 27 0.4× 57 0.9× 12 358
H. Altmannsberger Germany 7 234 0.8× 248 1.1× 145 1.4× 39 0.6× 83 1.3× 13 410
Hiromichi Shirasu Japan 10 232 0.8× 168 0.8× 96 0.9× 143 2.1× 58 0.9× 32 395
Virginia Palomar Coloma France 4 421 1.4× 190 0.9× 65 0.6× 48 0.7× 42 0.6× 5 481
Seung Tae Kim South Korea 9 186 0.6× 169 0.8× 89 0.8× 62 0.9× 67 1.0× 16 322
Jean Philippe Metges France 8 224 0.7× 124 0.6× 85 0.8× 76 1.1× 110 1.7× 23 343
N. Vardakis Greece 11 348 1.2× 201 0.9× 64 0.6× 113 1.7× 68 1.0× 35 436
Masafumi Tanaka Japan 8 298 1.0× 118 0.5× 140 1.3× 28 0.4× 56 0.9× 31 421
Sejung Park South Korea 10 155 0.5× 151 0.7× 120 1.1× 32 0.5× 44 0.7× 22 274

Countries citing papers authored by R. Camisa

Since Specialization
Citations

This map shows the geographic impact of R. Camisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Camisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Camisa more than expected).

Fields of papers citing papers by R. Camisa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Camisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Camisa. The network helps show where R. Camisa may publish in the future.

Co-authorship network of co-authors of R. Camisa

This figure shows the co-authorship network connecting the top 25 collaborators of R. Camisa. A scholar is included among the top collaborators of R. Camisa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Camisa. R. Camisa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Pellegrino, Benedetta, Claudia Omarini, Mirco Pistelli, et al.. (2022). Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer. The Breast. 65. 145–150. 9 indexed citations
3.
Cagnazzo, Celeste, et al.. (2016). Clinical Trial Units in Italy: the perception of the Clinical Research Coordinators. Annals of Oncology. 27. iv111–iv111. 2 indexed citations
4.
Negri, Francesca, Antonino Musolino, Nadia Naldi, et al.. (2013). Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy. The Pharmacogenomics Journal. 14(1). 14–19. 17 indexed citations
5.
Musolino, Antonino, Maria Angela Bella, Maria Michiara, et al.. (2012). Brca Status, Molecular Profile and Clinical Variables in Primary Bilateral Breast Cancers: A Population-Based Cancer Registry Study. Annals of Oncology. 23. ix175–ix176. 1 indexed citations
6.
Buti, Sebastiano, Paola Bordi, Marcello Tiseo, et al.. (2012). Erythrocyte Mean Corpuscular Volume Change During Pemetrexed Treatment in Advanced Non Small Cell Lung Cancer Patients. Annals of Oncology. 23. ix442–ix442. 1 indexed citations
7.
Bozzetti, Cecilia, Francesca Negri, Costanza Annamaria Lagrasta, et al.. (2011). Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma. British Journal of Cancer. 104(9). 1372–1376. 116 indexed citations
8.
Negri, Francesca, Cecilia Bozzetti, Costanza Annamaria Lagrasta, et al.. (2009). PTEN status in advanced colorectal cancer treated with cetuximab. British Journal of Cancer. 102(1). 162–164. 67 indexed citations
9.
Pizzi, Silvia, Cinzia Azzoni, Lorena Bottarelli, et al.. (2008). Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of  -catenin and chromosomal instability. Endocrine Related Cancer. 15(4). 1013–1024. 9 indexed citations
10.
Negri, Francesca, Nicoletta Campanini, R. Camisa, et al.. (2007). Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. British Journal of Cancer. 98(1). 143–147. 70 indexed citations
11.
Negri, Francesca, Antonino Musolino, Nadia Naldi, et al.. (2007). 522 POSTER Immunoglobulin G fragment C receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with cetuximab-based therapy. European Journal of Cancer Supplements. 5(4). 96–96. 3 indexed citations
12.
Passalacqua, Rodolfo, Carlo Buzio, Sebastiano Buti, et al.. (2007). Adjuvant low-dose interleukin-2 (IL2) plus interferone-alpha (IFN) in operable renal cell cancer (RCC). A phase III, randomized, multicenter, independent trial of the Italian Oncology Group for Clinical Research (GOIRC). Journal of Clinical Oncology. 25(18_suppl). LBA5028–LBA5028. 19 indexed citations
13.
14.
Passalacqua, Rodolfo, Carlo Buzio, R. Camisa, et al.. (2005). Phase III, randomized, multicentre trial of maintenance biotherapy with interleukin-2 (IL-2) and interferon-alpha (IFN) for metastatic renal cell cancer (RCC). Journal of Clinical Oncology. 23(16_suppl). 4605–4605. 3 indexed citations
15.
Cocconi, Giorgio, Paolo Carlini, Alessandro Gamboni, et al.. (2003). Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma. Annals of Oncology. 14(8). 1258–1263. 54 indexed citations
16.
Passalacqua, Rodolfo, Giorgio Cocconi, Anna Dodero, et al.. (1997). Long term results of neoadjuvant chemotherapy in patients with local-regional recurrence of melanoma. Melanoma Research. 7(Supplement 1). S119–S119. 1 indexed citations
17.
Paradiso, Angelo, Ruggero Dittadi, M. Correale, et al.. (1996). Cathepsin D versus Other Prognostic Factors in Breast Cancer. Results and Controversies of a Multicenter Study on 2575 Cases. The International Journal of Biological Markers. 11(3). 139–147. 1 indexed citations
18.
Nizzoli, Rita, Cecilia Bozzetti, Luisa Savoldi, et al.. (1995). Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.. PubMed. 38(6). 933–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anghel Adrian Udrea Breakdown of academic impact, for papers by C. Funaioli Breakdown of academic impact, for papers by H. Altmannsberger Breakdown of academic impact, for papers by Hiromichi Shirasu Breakdown of academic impact, for papers by Virginia Palomar Coloma Breakdown of academic impact, for papers by Seung Tae Kim Breakdown of academic impact, for papers by Jean Philippe Metges Breakdown of academic impact, for papers by N. Vardakis Breakdown of academic impact, for papers by Masafumi Tanaka Breakdown of academic impact, for papers by Sejung Park
Rankless by CCL
2026